Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 180.5 | 74 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 179.0 | 71 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 117.0 | 78 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 194.5 | 84 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 186.0 | 59 | |
| RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 68.0 | 69 | |
| RA2159 | PI103 | 0.1 | uM | 3 | IL-9 | 65.0 | 62 | ||||
| N2586 | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 225.5 | 84 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 183.0 | 82 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 206.0 | 60 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 193.0 | 69 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 127.0 | 53 | |
| N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-9 | 160.0 | 74 | |
| N2586 | PI103 | 0.1 | uM | 3 | IL-9 | 69.5 | 84 | ||||
| 0 | IL-9 | 49.0 | 71 | ||||||||
| RA2159 | TNF-a | 100 | ng/mL | 3 | IL-9 | 201.0 | 66 | ||||
| RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-9 | 166.0 | 64 | |
| RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-9 | 163.0 | 75 | |
| RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-9 | 203.5 | 84 | |
| RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-9 | 174.5 | 60 | |
| RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-9 | 83.0 | 76 | |
| RA2159 | EO1428 | 1.0 | uM | 3 | IL-9 | 73.5 | 72 | ||||
| N2586 | TNF-a | 100 | ng/mL | 3 | IL-9 | 234.0 | 67 | ||||
| N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-9 | 155.0 | 63 | |
| N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-9 | 178.0 | 57 |